Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure

American Journal of Cardiology

Volumn 95, Issue 7, 2005, Pages 827-831

  Bunch, T Jared ^b   Muhlestein, Joseph B ^a   Bair, Tami L ^b   Renlund, Dale G ^b   Lappé, Donald L ^b   Jensen, Kurt R ^b   Horne, Benjamin D ^b   Carter, Mathew A ^b   Anderson, Jeffrey L ^b  

^a LDS HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; DEMOGRAPHY; FEMALE; FOLLOW UP; HEART INFARCTION; HOSPITAL; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCRIPTION; PRIORITY JOURNAL; STENOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 15244360234     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.12.008     Document Type: Article

References (19)

1. B.D. Horne, J.B. Muhlestein, D.L. Lappé, D.G. Renlund, T.L. Bair, T.J. Bunch, J.L. Anderson Less affluent area of residence and lesser-insured status predict an increased risk of death or myocardial infarction after angiographic diagnosis of coronary disease Ann Epidemiol 14 2004 143 150
2. J.D. Jackson, J.B. Muhlestein, T.J. Bunch, T.L. Bair, B.D. Horne, T.E. Madsen, J.M. Lappe, J.L. Anderson Intermountain Heart Collaborative Study G Beta-blockers reduce the incidence of clinical restenosis: prospective study of 4840 patients undergoing percutaneous coronary revascularization Am Heart J 145 2003 875 881
3. R.N. Doughty, G.A. Whalley, H.A. Walsh, G.D. Gamble, J. Lopez-Sendon, N. Sharpe Investigators CES Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy Circulation 109 2004 201 206
4. M.R. Bristow, E.M. Gilbert, W.T. Abraham, K.F. Adams, M.B. Fowler, R.E. Hershberger, S.H. Kubo, K.A. Narahara, H. Ingersoll, S. Krueger Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure MOCHA Investigators Circulation 94 1996 2807 2816
5. S.D. Prabhu, B. Chandrasekar, D.R. Murray, G.L. Freeman Beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling Circulation 101 2000 2103 2109
6. R. Ricci, C. Coletta, V. Ceci, G. Pajes, R.L. Putini, A. Salustri, G. Bottero, M. Pasquale, R. Researchers Effect of early treatment with captopril and metoprolol singly and together on postinfarction left ventricular remodeling Am Heart J 142 2001 E5
7. Y.T. Sia, T.G. Parker, J.N. Tsoporis, P. Liu, A. Adam, J.L. Rouleau Long-term effects of carvedilol on left ventricular function, remodeling, and expression of cardiac cytokines after large myocardial infarction in the rat J Cardiovasc Pharmacol 39 2002 73 87
8. J. Galcera-Tomas, F.J. Castillo-Soria, M.M. Villegas-Garcia, R. Florenciano-Sanchez, J.G. Sanchez-Villanueva, J.A. de La Rosa, A. Martinez-Caballero, J.A. Valenti-Aldeguer, P. Jara-Perez, M. Parraga-Ramirez Effects of early use of atenolol or captopril on infarct size and ventricular volume: a double-blind comparison in patients with anterior acute myocardial infarction Circulation 103 2001 813 819
9. S.K. Sharma, A. Kini, J.D. Marmur, V. Fuster Cardioprotective effect of prior beta-blocker therapy in reducing creatine kinase-MB elevation after coronary intervention: benefit is extended to improvement in intermediate-term survival Circulation 102 2000 166 172
10. Anderson JL, Rodier HE, Green LS. Comparative effects of beta-adrenergic blocking drugs on experimental ventricular fibrillation threshold. Am J Cardiol 1983;51:1196-1202.
11. Dellsperger KC, Martins JB, Clothier JL, Marcus ML. Incidence of sudden cardiac death associated with coronary artery occlusion in dogs with hypertension and left ventricular hypertrophy is reduced by chronic β-adrenergic blockade. Circulation 1990;82:941-950.
12. Luketich J, Friehling TD, O'Connor KM, Kowey PR. The effect of beta adrenergic blockade on vulnerability to ventricular fibrillation and inducibility of ventricular arrhythmia in short- and long-term feline infarction models. Am Heart J 1989;118:265-271.
13. Rydén L, Ariniego R, Arnman K, Herlitz J, Hjarlmarson A, Holmberg S, Reyes C, Smedgård P, Svedberg K, Vedin A. A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias. N Engl J Med 1983;308:614-618.
14. Held P, Yusuf S. Early intravenous beta blockade in acute myocardial infarction. Cardiology 1989;76:132-143.
15. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981;304:801-807.
16. W.S. Aronow, C. Ahn Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and diabetes mellitus Am J Cardiol 87 2001 780 781
17. H.J. Dargie Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial Lancet 357 2001 1385 1390
18. A. Janosi, J.K. Ghali, J. Herlitz, I. Czuriga, M. Klibaner, J. Wikstrand, A. Hjalmarson, M.-H.S. Group Metoprolol CR/XL in postmyocardial infarction patients with chronic heart failure: experiences from MERIT-HF Am Heart J 146 2003 721 728
19. N. Freemantle, J. Cleland, P. Young, J. Mason, J. Harrison Beta blockade after myocardial infarction: systematic review and meta regression analysis BMJ 318 1999 1730 1737